Novo Nordisk A/S Class B (NOVOb)

1,049.0 +14.2 (+1.37%)
Close DKK Disclaimer

NOVOb Financial Summary

Novo Nordisk A/S reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported sales was DKK 48,092 million compared to DKK 38,333 million a year ago. Net income was DKK 13,592 million compared to DKK 10,892 million a year ago. Basic earnings per share from continuing operations was DKK 6.03 compared to DKK 4.77 a year ago. Diluted earnings per share from continuing operations was DKK 6.02 compared to DKK 4.76 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
NOVOb
Gross margin TTM 83.92%
Operating margin TTM 42.73%
Net Profit margin TTM 31.38%
Return on Investment TTM 58.55%
Total Revenue
Net Income
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Revenue 48,092 45,566 41,265 42,031
Gross Profit 39,830 38,366 35,196 35,114
Operating Income 17,898 20,184 18,391 19,147
Net Income 13,592 14,405 13,318 14,210
Clear All
0Selected
Please try another search
NOVOb
Quick Ratio MRQ 0.61
Current Ratio MRQ 0.89
LT Debt to Equity MRQ 24.88%
Total Debt to Equity MRQ 30.88%
Total Assets
Total Liabilities
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Total Assets 241,257 242,836 218,928 197,136
Total Liabilities 157,771 166,156 144,476 130,586
Total Equity 83,486 76,680 74,452 66,550
Clear All
0Selected
Please try another search
NOVOb
Cash Flow/Share TTM 34.92
Revenue/Share TTM 78.34
Operating Cash Flow 5.87%
Cash
Net Change in Cash
Title
Dec 31, 2022
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Cash From Operating Activities 7,101 24,239 23,961 23,586
Cash From Investing Activities -13,850 -4,961 -4,200 -1,907
Cash From Financing Activities -7,668 -14,563 -10,431 -19,135
Net Change in Cash -15,261 5,158 9,548 2,489
Clear All
0Selected
Please try another search

* In Millions of DKK (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles